ArticleOncotarget2016

Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesothelioma.

Shenqi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.